↓ Skip to main content

Dove Medical Press

Axillary and internal mammary sentinel lymph node biopsy in male breast cancer patients: case series and review

Overview of attention for article published in OncoTargets and therapy, June 2015
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley
Title
Axillary and internal mammary sentinel lymph node biopsy in male breast cancer patients: case series and review
Published in
OncoTargets and therapy, June 2015
DOI 10.2147/ott.s84659
Pubmed ID
Authors

Xiaoshan Cao, Chunjian Wang, Yanbing Liu, Pengfei Qiu, Binbin Cong, Yongsheng Wang

Abstract

Male breast cancer (MBC) is considered as a rare disease that accounts for less than 1% of all breast cancers, and its treatment has been based on the evidence available from female breast cancer. Axillary sentinel lymph node biopsy (SLNB) is now regarded as the standard of care for both female and male patients without clinical and imaging evidence of axillary lymph node metastases, while internal mammary SLNB has rarely been performed. Internal mammary chain metastasis is an independent prognostic predictor. Internal mammary SLNB should be performed to complete nodal staging and guide adjuvant therapy in MBC patients with preoperative lymphoscintigraphic internal mammary chain drainage. We report both axillary and internal mammary SLNB in two cases with MBC. Internal mammary sentinel lymph node did contain metastasis in one case.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 25%
Student > Ph. D. Student 2 25%
Student > Bachelor 1 13%
Researcher 1 13%
Professor > Associate Professor 1 13%
Other 0 0%
Unknown 1 13%
Readers by discipline Count As %
Medicine and Dentistry 2 25%
Economics, Econometrics and Finance 2 25%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Unknown 3 38%